| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6650W303H0 |
| InChI Key | KVHRYLNQDWXAGI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H17FN6O2 |
| Molecular Weight | 428.43 |
| AlogP | 3.42 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 79.76 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 5.0 |
| Heavy Atoms | 32.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Phosphodiesterase 10A inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3989972 |
| DrugBank | DB14774 |
| FDA SRS | 6650W303H0 |
| PDB | 3K9 |
| PubChem | 46848915 |
| SureChEMBL | SCHEMBL518714 |
| ZINC | ZINC000114005494 |